about
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...
Read More
2.87
-0.01
(-0.35%)
193.4K
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Genelux Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..